Literature DB >> 24041968

Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from control.

Tessandra Stewart1, Yu-Ting Sui, Luis F Gonzalez-Cuyar, David T W Wong, David M Akin, Vitor Tumas, Jan Aasly, Emily Ashmore, Patrick Aro, Carmen Ginghina, Ane Korff, Cyrus P Zabetian, James B Leverenz, Min Shi, Jing Zhang.   

Abstract

Recently, α-synuclein (α-syn) and DJ-1, 2 proteins critically involved in Parkinson's disease (PD), have been shown to be present in saliva, suggesting their potential utility as biomarkers of PD. However, the origin and influence of demographic characteristics (e.g., age or sex) on these proteins are unknown. We identified cheek epithelium, which forms the majority of the cellular component of saliva and is readily accessible clinically, as 1 of several potential sources of salivary α-syn and DJ-1. However, no PD-related trend in the cellular component was present. In the supernatant collected from 198 healthy subjects, no correlation was seen between salivary DJ-1 or α-syn with age. When male and female subjects were analyzed separately, a weak age-dependent increase in DJ-1 level was present in male subjects, along with slightly increased α-syn in female subjects. These results, albeit largely negative, provide critical information for understanding the salivary gland pathology and saliva as a PD biomarker source, and must be considered in future investigations of salivary changes in PD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarker; DJ-1; Movement disorder; Neurodegeneration; Parkinson's disease; Saliva; α-Synuclein

Mesh:

Substances:

Year:  2013        PMID: 24041968      PMCID: PMC3844543          DOI: 10.1016/j.neurobiolaging.2013.08.008

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  4 in total

1.  Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients.

Authors:  Maria Graciela Cersósimo; Claudia Perandones; Federico Eduardo Micheli; Gabriela Beatriz Raina; Ana Maria Beron; Gustavo Nasswetter; Martin Radrizzani; Eduardo Elias Benarroch
Journal:  Mov Disord       Date:  2010-09-10       Impact factor: 10.338

2.  Salivary α-synuclein and DJ-1: potential biomarkers for Parkinson's disease.

Authors:  Ivana Devic; Hyejin Hwang; John Scott Edgar; Kenneth Izutsu; Richard Presland; Catherine Pan; David R Goodlett; Yu Wang; Jeff Armaly; Vitor Tumas; Cyrus P Zabetian; James B Leverenz; Min Shi; Jing Zhang
Journal:  Brain       Date:  2011-02-24       Impact factor: 13.501

3.  Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease.

Authors:  Kelly Del Tredici; Christopher H Hawkes; Estifanos Ghebremedhin; Heiko Braak
Journal:  Acta Neuropathol       Date:  2010-03-14       Impact factor: 17.088

4.  Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders.

Authors:  Thomas G Beach; Charles H Adler; Lucia I Sue; Linda Vedders; Lihfen Lue; Charles L White Iii; Haru Akiyama; John N Caviness; Holly A Shill; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2010-03-21       Impact factor: 17.088

  4 in total
  11 in total

1.  Salivary alpha-synuclein as a biomarker for Parkinson's disease: a systematic review.

Authors:  Anastasia Bougea; Christos Koros; Leonidas Stefanis
Journal:  J Neural Transm (Vienna)       Date:  2019-08-10       Impact factor: 3.575

Review 2.  Laboratory assessments in the course of Parkinson's disease: a clinician's perspective.

Authors:  Thomas Müller; Horst Baas; Jan Kassubek; Peter Riederer; Peter Paul Urban; Christoph Schrader; Heinz Reichmann; Dirk Woitalla; Manfred Gerlach
Journal:  J Neural Transm (Vienna)       Date:  2015-11-14       Impact factor: 3.575

Review 3.  Alpha-Synuclein as a Biomarker for Parkinson's Disease.

Authors:  Anzari Atik; Tessandra Stewart; Jing Zhang
Journal:  Brain Pathol       Date:  2016-05       Impact factor: 6.508

Review 4.  Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases.

Authors:  Giovanni Schepici; Serena Silvestro; Oriana Trubiani; Placido Bramanti; Emanuela Mazzon
Journal:  Brain Sci       Date:  2020-04-21

5.  Salivary alpha-synuclein as a potential fluid biomarker in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Sanjeev Kharel; Rajeev Ojha; Anil Bist; Surya Prakash Joshi; Robin Rauniyar; Jayant Kumar Yadav
Journal:  Aging Med (Milton)       Date:  2022-01-24

Review 6.  Systematic Review on Saliva Biomarkers in Patients Diagnosed with Morbus Alzheimer and Morbus Parkinson.

Authors:  Michael Wolgin; Magdalena Zobernig; Valentyn Dvornyk; Ralf J Braun; Andrej M Kielbassa
Journal:  Biomedicines       Date:  2022-07-14

7.  Native α-Synuclein, 3-Nitrotyrosine Proteins, and Patterns of Nitro-α-Synuclein-Immunoreactive Inclusions in Saliva and Submandibulary Gland in Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Juan Suárez; Eduardo Tolosa; Dolores Vilas; Iban Aldecoa; Joan Berenguer; Fátima Damas-Hermoso
Journal:  Antioxidants (Basel)       Date:  2021-05-01

8.  Salivary DJ-1 could be an indicator of Parkinson's disease progression.

Authors:  Wen-Yan Kang; Qiong Yang; Xu-Feng Jiang; Wei Chen; Lin-Yuan Zhang; Xiao-Ying Wang; Li-Na Zhang; Thomas J Quinn; Jun Liu; Sheng-Di Chen
Journal:  Front Aging Neurosci       Date:  2014-06-06       Impact factor: 5.750

9.  Salivary total α-synuclein, oligomeric α-synuclein and SNCA variants in Parkinson's disease patients.

Authors:  Wenyan Kang; Wei Chen; Qiong Yang; Lina Zhang; Linyuan Zhang; Xiaoying Wang; Fangyi Dong; Yang Zhao; Shuai Chen; Thomas J Quinn; Jing Zhang; Shengdi Chen; Jun Liu
Journal:  Sci Rep       Date:  2016-06-23       Impact factor: 4.379

Review 10.  Diagnostic biomarkers for Parkinson's disease at a glance: where are we?

Authors:  Ilaria Cova; Alberto Priori
Journal:  J Neural Transm (Vienna)       Date:  2018-08-25       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.